Home / Business and Economy / BWXT Fuels Nuclear Market Boom with Strong Earnings
BWXT Fuels Nuclear Market Boom with Strong Earnings
4 Aug
Summary
- BWXT reported 18% revenue growth and raised its financial outlook for 2026.
- The company sees a multi-decade growth cycle in the nuclear industry.
- BWXT is selling over 80% of its medical business for up to $800 million.
BWX Technologies (BWXT) revealed an 18% year-over-year revenue increase for its second quarter of 2026, alongside an upward revision of its full-year financial guidance. This positive performance stems from robust demand across both national security and commercial nuclear power sectors. The company's leadership anticipates the nuclear industry is at the dawn of a significant, multi-decade expansion.
BWXT is set to sell more than 80% of its medical business and associated stable-isotope enrichment operations for a potential total of $800 million. This strategic divestiture aims to allow BWXT to concentrate its resources more effectively on its nuclear national security and commercial power ventures, while the medical assets transition to a new owner focused on the healthcare market. The company's second-quarter results included $902 million in revenue and $156 million in adjusted EBITDA. BWXT's backlog grew to $8.4 billion, marking a 40% increase from the previous year, and its book-to-bill ratio stood at 1.7 times over the last twelve months.
